Stay updated on Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe NIH website transition announcement banner was removed from the top of the page; the 403 error message and study page content remain unchanged.SummaryDifference1%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden message rather than study details.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide notice was added announcing updates and FAQs about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer's site revision changes from v3.7.1 to v3.7.2. The study page remains an access-denied 403 screen.SummaryDifference0.2%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.3%

- Check45 days agoChange DetectedThe page remains a 403 Forbidden error screen, with no study record content displayed.SummaryDifference0.2%

Stay in the know with updates to Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.